InvestorsHub Logo
Followers 24
Posts 1345
Boards Moderated 0
Alias Born 01/24/2004

Re: The oNiOnHEAd post# 123388

Wednesday, 10/14/2020 2:29:30 PM

Wednesday, October 14, 2020 2:29:30 PM

Post# of 233268
Its noteworthy that even though OncoImmune's Phase 2 trial supposedly showed statistical efficacy in reducing deaths, the study did not get halted at interim, and at conclusion the drug did not get some kind of approval. I don't know anything about the adverse effects statistics, but I would suspect that Big Pharma has targeted not only CytoDyn, but OncoImmune, as well.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News